Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -180,091 | -128,518 | -92,879 | -53,867 | -169,431 |
| Depreciation Amortization | 25,996 | 28,923 | 18,216 | 8,988 | 35,057 |
| Accounts receivable | 853 | 2,577 | 4,056 | 2,851 | 2,301 |
| Accounts payable and accrued liabilities | 2,467 | -4,325 | -632 | 5,043 | -6,036 |
| Other Working Capital | 80,775 | 64,805 | 28,799 | 1,646 | -26,042 |
| Other Operating Activity | 55,208 | 48,623 | 22,462 | 8,865 | 121,408 |
| Operating Cash Flow | $-14,792 | $12,085 | $-19,978 | $-26,474 | $-42,743 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -113,472 | -126,042 | -163,936 | -96,436 | 58,518 |
| PPE Investments | -5,101 | -4,947 | -4,598 | -4,495 | -6,767 |
| Purchase Sale Intangibles | -19,050 | -14,004 | -8,979 | -4,775 | -17,799 |
| Other Investing Activity | -19,050 | -14,004 | -8,979 | -4,775 | -113,078 |
| Investing Cash Flow | $-137,623 | $-144,993 | $-177,513 | $-105,706 | $-61,327 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 237,775 | 200,835 | 197,230 | 197,010 | 135,415 |
| Other Financing Activity | -6,092 | -2,365 | -1,174 | -1,257 | -7,702 |
| Financing Cash Flow | $231,683 | $198,470 | $196,056 | $195,753 | $127,713 |
| Exchange Rate Effect | 1,713 | -7 | -49 | -113 | -1,307 |
| Beginning Cash Position | 84,772 | 84,772 | 84,772 | 84,772 | 62,436 |
| End Cash Position | 165,753 | 150,327 | 83,288 | 148,232 | 84,772 |
| Net Cash Flow | $80,981 | $65,555 | $-1,484 | $63,460 | $22,336 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,792 | 12,085 | -19,978 | -26,474 | -42,743 |
| Capital Expenditure | -5,101 | -4,947 | -4,598 | -4,495 | -6,767 |
| Free Cash Flow | -19,893 | 7,138 | -24,576 | -30,969 | -49,510 |